Machine signal
Active cluster sell — 6 distinct insiders, $1.7M, window ends Sep 29, 2026.
Figures computed from official regulatory filings — .
Analysttarget 31.85 USD (+200%) · consensus 4.69/5 · 15 buy · 1 hold · 0 sell
Ownershipinsiders 1.4% · institutions 100% · short 17.1% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Kura Oncology, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
15 buys111 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Leoni Mollie | Sell | $309.6K | SEC |
| Powl Brian T. | Sell | $165.9K | Unusual size | SEC |
| Powl Brian T. | Sell | $84.5K | SEC |
| Powl Brian T. | Sell | $94.7K | SEC |
| FORD KATHLEEN | Sell | $39.4K | SEC |
| FORD KATHLEEN | Sell | $72.5K | SEC |
| Leoni Mollie | Sell | $130.7K | SEC |
| DOYLE THOMAS JAMES | Sell | $48.4K | Unusual size | SEC |
| Bair Teresa Brophy | Sell | $88.6K | SEC |
| Burrows Francis | Exercise | $184.5K | SEC |
| Burrows Francis | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Burrows Francis | Sell | $224.5K | SEC |
| Fulk Jennifer | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Powl Brian T. | Sell | $51.7K | SEC |
| WILSON TROY EDWARDtrack record | Buy | $1.2M | conv 39 | SEC |
| Bair Teresa Brophy | Sell | $397.7K | Unusual size | SEC |
| WILSON TROY EDWARDtrack record | Buy | $1.1M | conv 53Unusual size | SEC |
| Leoni Mollie | Sell | $834.3K | Unusual size | SEC |
| Parks Diane L. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| VASCONCELLES MICHAEL | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Collins Helen Louise | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Szela Mary Ttrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Hasnain Faheemtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Malley Thomastrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| SCHAFER CAROL | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |